These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34232158)

  • 61. Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.
    Wang Q; Wang Y; Wang J; Zhang L; Zhao MH;
    J Am Heart Assoc; 2020 Jun; 9(12):e015359. PubMed ID: 32508195
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trends in population blood pressure and determinant factors for population blood pressure.
    Andersen UO
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260600
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010.
    Liu W; Weng S; Cao C; Yi Y; Wu Y; Peng D
    Ren Fail; 2024 Dec; 46(1):2352126. PubMed ID: 38832474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients.
    Li Y; Li D; Song Y; Gao L; Fan F; Wang B; Liang M; Wang G; Li J; Zhang Y; Xu X; Hou FF; Cheng X; Sun N; Sun Y; Zhao L; Wan Q; Li X; Li J; Han Q; Xu X; Huo Y; Qin X
    Nephrol Dial Transplant; 2020 Oct; 35(10):1739-1746. PubMed ID: 31102525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study.
    Bae EH; Lim SY; Kim B; Oh TR; Song SH; Suh SH; Choi HS; Yang EM; Kim CS; Ma SK; Han KD; Kim SW
    Hypertension; 2022 Aug; 79(8):1765-1776. PubMed ID: 35607989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes.
    Raghavan S; Ho YL; Kini V; Rhee MK; Vassy JL; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    Diabetes Care; 2019 Oct; 42(10):1995-2003. PubMed ID: 31515207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blood pressure control in patients with chronic kidney disease according to office and home blood pressures.
    Chantrel F; Ott J; Dimitrov Y; Babici D; Fourcade J; Hanon O; Achard JM; Jabourek O; Ducher M; Fauvel JP;
    Blood Press Monit; 2020 Oct; 25(5):246-251. PubMed ID: 32842021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical correlates of ambulatory BP monitoring among patients with CKD.
    Iimuro S; Imai E; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Ohashi Y; Hishida A;
    Clin J Am Soc Nephrol; 2013 May; 8(5):721-30. PubMed ID: 23411432
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease.
    Kovesdy CP; Lu JL; Molnar MZ; Ma JZ; Canada RB; Streja E; Kalantar-Zadeh K; Bleyer AJ
    JAMA Intern Med; 2014 Sep; 174(9):1442-9. PubMed ID: 25089540
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study].
    Zhou T; Liu Q; Zhang M; Liu X; Kang J; Shen P; Lin H; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):441-447. PubMed ID: 38864129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study.
    Ito H; Mifune M; Abe M; Oshikiri K; Antoku S; Takeuchi Y; Togane M; Ando S; Tsugami E
    BMC Nephrol; 2012 Jun; 13():48. PubMed ID: 22738384
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients.
    Lee H; Kwon SH; Jeon JS; Noh H; Han DC; Kim H
    Kidney Res Clin Pract; 2022 Jan; 41(1):31-42. PubMed ID: 34974658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study.
    Tsuchida-Nishiwaki M; Uchida HA; Takeuchi H; Nishiwaki N; Maeshima Y; Saito C; Sugiyama H; Wada J; Narita I; Watanabe T; Matsuo S; Makino H; Hishida A; Yamagata K
    Sci Rep; 2021 Jul; 11(1):14990. PubMed ID: 34294784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.
    Suttorp MM; Hoekstra T; Mittelman M; Ott I; Franssen CF; Dekker FW
    PLoS One; 2013; 8(12):e84848. PubMed ID: 24391978
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
    Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.